Key terms
About BIOMER1.5%29JUN27
Sector
Health Technology
Industry
Medical Specialties
Home page
ISIN
FR0013520657
FIGI
BBG00W9LPLL6
bioMérieux SA engages in the provision of in vitro diagnostic solutions, which determine the source of disease and contamination. It develops testing, detection, and other laboratory system for the analysis of cancer, diseases, and infections caused by bacteria, virus, and fungi. The company was founded Alain Mérieux in 1963 and is headquartered in Marcy l'Etoile, France.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.